Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 1Stomach Neoplasms 1Sigmoid Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Liver Neoplasms 1Kidney Neoplasms 1Fractures, Bone 1Emergence Delirium 1Colonic Neoplasms 1

Interventions

Docetaxel 277Prednisone 237enzalutamide 177Leuprolide 172Radiotherapy 164Abiraterone Acetate 154Magnetic Resonance Spectroscopy 147bicalutamide 137Goserelin 134Androgen Antagonists 111Radiosurgery 101acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 100apalutamide 79abiraterone 77gallium 68 PSMA-11 74Specimen Handling 67darolutamide 58Gonadotropin-Releasing Hormone 58Radiation 56Triptorelin Pamoate 53cabazitaxel 50Zoledronic Acid 49pembrolizumab 48Radiotherapy, Intensity-Modulated 47Flutamide 47Brachytherapy 47luprolide acetate gel depot 46Standard of Care 45Carboplatin 44Estramustine 43

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Prostatic Neoplasms × Neuroleptanalgesia × Clear all
NCT05068180 2021-10-06

Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients

RenJi Hospital

Phase 4 Unknown
200 enrolled
GastrointestinalGenitourinary

Emergence Delirium, Urinary Bladder Neoplasms, Colonic Neoplasms, Kidney Neoplasms, Liver Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Sigmoid Neoplasms, Stomach Neoplasms, Fractures, Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡